Work

PD-076 Phase II randomized trial of irinotecan/docetaxel oririnotecan/gemcitabine with or without celecoxib in 2nd-line treatment of non-small-cell lung cancer

Year: 2005

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1016/s0169-5002(05)80409-x

Authors: R. Lilenbaum, M. Socinski, N. Altorki, L. Hart, R. Keresztes, S. Hariharan, M. Morrison, R. Fayyad, P. Bonomi

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2089220265

Cites:

Cited by: 7

Related to: 10